Hubli M, Dietz V, Bolliger M
Hematocrit value at early middle age predicts hypertension at late middle age
To view or add a comment, sign in A new study from The Ohio State University College of Medicine says Mark Cuban Cost Plus Drug Company, PBC could upend traditional prescription coverage
For arthritis and musculoskeletal pain, the data can be summarized in one sentence: There is no credible human evidence that BPC-157 works, and real risks exist due to poor-quality manufacturing and illegal distribution
A healthcare provider can determine whether treatment is appropriate based on individual circumstances
Anecdotes are all over social media, but more importantly pharmaceutical companies are taking note of these anecdotes and starting to run trials for a plethora of indications